13F reference period
Q3 2026
CUSIP: 00654F105
13F reference period
Q3 2026
Institutions Reporting
53
Shares (Excl. Options)
Price
$19.94
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 53 institutions filings for Q3 2026.
Security key
00654F105
13F reference period
Q3 2026
13F holders
53
13D/G owners
5
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 00654F105:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 14% | 14,913,764 | ORBIMED ADVISORS LLC | 28 Sep 2026 | ||||
| LAV Biosciences Fund V, L.P. | 11% | $244,762,639 | 11,858,655 | Yi Shi | 30 Sep 2026 | |||
| Li Zhen | 9.6% | $191,177,594 | 10,800,994 | Zhen Li | 30 Sep 2026 | |||
| SR ONE CAPITAL MANAGEMENT, LLC | 9.3% | 9,936,661 | SR One Capital Management, LLC | 28 Sep 2026 | ||||
| BCLS Fund III Investments, LP | 6.3% | 6,728,970 | BCLS Fund III Investments, LP | 24 Sep 2026 |
13F concentration
Largest 13F positions for this security by reported shares and value.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 22% | 24,205,789 | 8.9% | $482,663,433 | |
| SR ONE CAPITAL MANAGEMENT, LP | 8.8% | 9,936,661 | 17% | $198,137,020 | |
| Bain Capital Life Sciences Investors, LLC | 6% | 6,728,970 | 9% | $134,175,662 | |
| TCG Crossover Management, LLC | 3.7% | 4,116,452 | 2.3% | $82,082,053 | |
| Capital International Investors | 1.9% | 2,132,301 | 0.01% | $42,518,082 | |
| Siren, L.L.C. | 1.7% | 1,925,794 | 0.91% | $38,400,332 | |
| ALLIANCEBERNSTEIN L.P. | 1.5% | 1,719,816 | 0.01% | $34,293,131 | |
| Venrock Adviser, LLC | 1.4% | 1,625,793 | 1.6% | $32,418,312 | |
| T. Rowe Price Investment Management, Inc. | 1.4% | 1,605,227 | 0.02% | $32,009,000 | |
| Woodline Partners LP | 1.3% | 1,463,478 | 0.09% | $29,181,751 | |
| MARSHALL WACE, LLP | 1.2% | 1,333,496 | 0.03% | $26,589,911 | |
| Commodore Capital LP | 1.1% | 1,260,577 | 1.9% | $25,135,905 | |
| Capital World Investors | 1.1% | 1,200,000 | 0% | $23,928,000 | |
| EcoR1 Capital, LLC | 1% | 1,150,000 | 1.1% | $22,931,000 | |
| Cormorant Asset Management, LP | 0.86% | 962,898 | 1.3% | $19,200,176 | |
| Redmile Group, LLC | 0.68% | 769,345 | 1.1% | $15,340,739 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 0.58% | 650,360 | 0% | $12,968,178 | |
| GordonMD Global Investments LP | 0.4% | 450,000 | 5.9% | $8,973,000 | |
| Blackstone Inc. | 0.37% | 421,701 | 0.03% | $8,408,718 | |
| RTW INVESTMENTS, LP | 0.27% | 300,000 | 0.06% | $5,982,000 | |
| PERCEPTIVE ADVISORS LLC | 0.27% | 300,000 | 0.11% | $5,982,000 | |
| BRAIDWELL LP | 0.27% | 300,000 | 0.25% | $5,982,000 | |
| Vivo Capital, LLC | 0.23% | 255,158 | 0.56% | $5,087,851 | |
| GOLDMAN SACHS GROUP INC | 0.16% | 181,300 | 0% | $3,615,122 | |
| SEVEN GRAND MANAGERS, LLC | 0.13% | 149,369 | 0.12% | $2,978,418 |
Quarter history
Holder count, reported shares/value, and median price by quarter.
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 67,421,536 | $1,339,969,498 | +$1,339,470,998 | $19.94 | 53 |